アステラス製薬の業績推移
(単位:百万円)
|
売上高 |
営業利益 |
経常利益 |
純利益 |
売上原価 |
売上総利益 |
株主資本 |
総負債 |
総資産 |
現金及び現金同等物 |
流動市場性有価証券 |
流動資産 |
流動負債 |
利益剰余金 |
営業利益率 |
経常利益率 |
当期利益率 |
自己資本比率 |
営業キャッシュフロー |
投資キャッシュフロー |
財務キャッシュフロー |
営業キャッシュフローマージン |
フリーキャッシュフロー |
ROE |
ROA |
一株あたり利益 |
希薄化後一株あたり利益 |
従業員数 |
2024年3月
|
1,603,672
|
25,518
|
24,969
|
17,045
|
292,485
|
1,311,187
|
1,595,988
|
1,973,615
|
3,569,603
|
335,687
|
|
1,194,730
|
1,285,725
|
809,400
|
1.59%
|
1.56%
|
1.06%
|
44.71%
|
172,475
|
-845,802
|
614,060
|
10.76%
|
-673,327
|
1.1%
|
0.57%
|
0.00000951
|
0.00016287
|
1万4754人
|
2023年3月
|
1,518,619
|
133,029
|
132,361
|
98,714
|
288,353
|
1,230,266
|
1,507,954
|
948,564
|
2,456,518
|
376,840
|
|
1,049,954
|
726,034
|
908,158
|
8.76%
|
8.72%
|
6.5%
|
61.39%
|
327,767
|
-84,500
|
-195,623
|
21.58%
|
243,267
|
6.65%
|
4.12%
|
0.00005424
|
0.00017257
|
1万4484人
|
2022年3月
|
1,296,163
|
155,686
|
156,886
|
124,086
|
253,009
|
1,043,154
|
1,460,308
|
872,087
|
2,332,395
|
315,986
|
|
923,354
|
687,411
|
944,261
|
12.01%
|
12.1%
|
9.57%
|
62.61%
|
257,444
|
-62,413
|
-216,298
|
19.86%
|
195,031
|
8.72%
|
5.39%
|
0.00006708
|
0.00012163
|
1万4522人
|
2021年3月
|
1,249,528
|
136,051
|
145,324
|
120,589
|
246,063
|
1,003,465
|
1,386,115
|
887,513
|
2,273,628
|
326,128
|
|
872,588
|
592,372
|
953,289
|
10.89%
|
11.63%
|
9.65%
|
60.96%
|
306,843
|
-81,894
|
-229,479
|
24.56%
|
224,949
|
9.02%
|
5.26%
|
0.00006493
|
0.00010389
|
1万5455人
|
2020年3月
|
1,300,843
|
243,991
|
245,350
|
195,411
|
276,739
|
1,024,104
|
1,289,168
|
1,026,001
|
2,315,169
|
318,391
|
|
867,514
|
798,708
|
905,851
|
18.76%
|
18.86%
|
15.02%
|
55.68%
|
221,998
|
-389,793
|
181,055
|
17.07%
|
-167,795
|
15.34%
|
9.28%
|
0.00010415
|
0.00012817
|
1万5883人
|
2019年3月
|
1,306,348
|
243,912
|
248,967
|
222,265
|
292,050
|
1,014,298
|
1,258,396
|
639,252
|
1,897,648
|
311,074
|
|
857,159
|
497,665
|
991,957
|
18.67%
|
19.06%
|
17.01%
|
66.31%
|
258,630
|
-41,757
|
-233,681
|
19.8%
|
216,873
|
17.59%
|
11.84%
|
0.00011505
|
|
1万6243人
|
2018年3月
|
1,300,316
|
213,258
|
218,113
|
164,679
|
294,250
|
1,006,066
|
1,268,289
|
589,916
|
1,858,205
|
331,731
|
|
845,619
|
421,620
|
976,076
|
16.4%
|
16.77%
|
12.66%
|
68.25%
|
312,614
|
-121,799
|
-203,429
|
24.04%
|
190,815
|
12.97%
|
8.97%
|
0.00008111
|
|
1万6617人
|
2017年3月
|
1,311,665
|
260,830
|
281,769
|
218,701
|
|
|
1,271,810
|
542,262
|
1,814,072
|
340,923
|
|
|
|
|
19.89%
|
21.48%
|
16.67%
|
70.11%
|
235,612
|
-73,383
|
-166,153
|
17.96%
|
162,229
|
17.28%
|
12.1%
|
0.00010369
|
0.00010355
|
1万7202人
|
2016年3月
|
1,372,706
|
248,986
|
261,770
|
193,687
|
266,857
|
1,105,849
|
1,259,209
|
540,129
|
1,799,338
|
360,030
|
|
|
|
|
18.14%
|
19.07%
|
14.11%
|
69.98%
|
313,737
|
-147,050
|
-193,478
|
22.86%
|
166,687
|
15.03%
|
10.78%
|
0.00008975
|
0.00008962
|
1万7217人
|
2015年3月
|
1,247,259
|
185,663
|
189,683
|
135,856
|
|
|
1,317,916
|
475,662
|
1,793,578
|
396,430
|
|
|
|
|
14.89%
|
15.21%
|
10.89%
|
73.48%
|
187,686
|
-71,476
|
-121,118
|
15.05%
|
116,210
|
10.51%
|
7.88%
|
0.0000615
|
0.0000614
|
1万7113人
|
2014年3月
|
1,164,514
|
116,806
|
170,792
|
90,874
|
|
|
1,268,476
|
384,632
|
1,653,108
|
391,374
|
|
|
|
|
10.03%
|
14.67%
|
7.8%
|
76.73%
|
214,257
|
-26,851
|
-89,395
|
18.4%
|
187,406
|
7.44%
|
5.65%
|
0.00004115
|
0.00004108
|
1万7649人
|
2013年3月
|
1,005,612
|
|
157,156
|
92,464
|
|
|
1,174,606
|
390,665
|
1,565,271
|
264,912
|
|
|
|
|
0.0%
|
15.63%
|
9.19%
|
75.04%
|
150,926
|
-55,101
|
-110,013
|
15.01%
|
95,825
|
8.04%
|
6.01%
|
0.00004027
|
0.00003603
|
1万7454人
|
2012年3月
|
969,387
|
|
135,108
|
78,231
|
|
|
1,125,157
|
385,904
|
1,511,061
|
252,380
|
|
|
|
|
0.0%
|
13.94%
|
8.07%
|
74.46%
|
172,676
|
-25,954
|
-57,938
|
17.81%
|
146,722
|
|
|
0.00016938
|
0.00016917
|
1万7085人
|
2011年3月
|
953,947
|
|
115,058
|
67,650
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
12.06%
|
7.09%
|
|
|
|
|
|
|
|
|
0.00014649
|
0.00014633
|
1万6279人
|
2010年3月
|
974,877
|
|
190,986
|
122,257
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
19.59%
|
12.54%
|
|
|
|
|
|
|
|
|
0.00026184
|
0.00026162
|
1万5161人
|